All ProductsDisplaying Products by Catalog Number (1400 - 1499)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
Cat. No. | Product Name / Activity |
---|---|
1400 | SCH 202676 hydrobromide |
Inhibitor of ligand binding to G-protein-coupled receptors | |
1402 | SB 203580 hydrochloride |
Selective inhibitor of p38 MAPK; water-soluble | |
1403 | FPL 64176 |
Potent CaV1.x activator | |
1406 | Trichostatin A |
Potent histone deacetylase inhibitor | |
1407 | PP 2 |
Potent, selective Src family kinase inhibitor | |
1408 | YM 022 |
Highly potent, selective non-peptide CCK2 antagonist | |
1412 | Chromanol 293B |
IKs blocker. Also blocks ICFTR | |
1414 | Scopolamine hydrobromide |
Non-selective muscarinic antagonist | |
1415 | 1400W dihydrochloride |
Potent, highly selective iNOS inhibitor | |
1416 | Homoharringtonine |
Inhibitor of protein synthesis; antileukemic agent | |
1418 | Resveratrol |
Cyclooxygenase inhibitor | |
1422 | DCEBIO |
Activates Cl- conductance and hKCa3.1 channels | |
1425 | (S)-(+)-Dimethindene maleate |
Selective M2 antagonist | |
1426 | PPT |
Subtype-selective ERα agonist | |
1427 | Citalopram hydrobromide |
Highly potent and selective 5-HT uptake inhibitor | |
1428 | Amyloid β-Peptide (1-42) (human) |
Predominant amyloid β-protein fragment | |
1429 | Amyloid β-peptide (25-35) (human) |
Human amyloid β-protein fragment functionally required for neurotoxicity | |
1430 | DuP 697 |
Cyclooxygenase-2 (COX-2) inhibitor | |
1431 | DPDPE |
Selective δ agonist | |
1435 | SQ 22536 |
Adenylyl cyclase inhibitor | |
1437 | D609 |
Selective PC-PLC inhibitor | |
1439 | Ruthenium Red |
Non-selective CaV2.1 and 2.2 blocker; also blocks TRPV channels | |
1443 | Metastin (human) |
Potent, endogenous ligand for kisspeptin receptor | |
1447 | SKF 81297 hydrobromide |
D1 agonist | |
1448 | Formoterol hemifumarate |
Potent and selective β2 agonist | |
1453 | Clemastine fumarate |
H1 antagonist | |
1454 | GYKI 52466 dihydrochloride |
Selective non-competitive AMPA antagonist | |
1455 | Orexin A (human, rat, mouse) |
Endogenous agonist at OX1 and OX2 | |
1456 | Orexin B (human) |
Endogenous agonist at OX1 and OX2 | |
1457 | Orexin B (mouse) |
Endogenous agonist at OX1 and OX2 | |
1462 | AACOCF3 |
Phospholipase A2 inhibitor | |
1463 | Ghrelin (human) |
Endogenous ghrelin receptor agonist | |
1464 | TFLLR-NH2 |
PAR1-activating peptide | |
1465 | Ghrelin (rat) |
Endogenous ghrelin receptor agonist | |
1467 | Daunorubicin hydrochloride |
DNA topoisomerase II inhibitor | |
1468 | SLIGRL-NH2 |
PAR2-activating peptide | |
1469 | CGP 37849 |
Potent and selective NMDA antagonist | |
1470 | Flecainide acetate |
Cardiac Na+ channel blocker. Antiarrhythmic | |
1471 | Etomidate |
GABA-mimetic; selectively interacts with β2- and β3-subunit containing GABAA receptors | |
1472 | Suramin hexasodium salt |
Non-selective P2 antagonist | |
1475 | (-)-[3R,4S]-Chromanol 293B |
IKs blocker. Enantiomer of Chromanol 293B (Cat. No. 1412) | |
1476 | Gap 27 |
Selective gap junction blocker | |
1477 | GR 127935 hydrochloride |
Potent and selective 5-HT1B and 5-HT1D antagonist | |
1478 | Proglumide sodium salt |
Non-selective CCK antagonist; orally active | |
1479 | Mifepristone |
Progesterone and glucocorticoid receptor antagonist | |
1482 | D-myo-Inositol 1,4,5-trisphosphate, hexapotassium salt |
Ca2+ mobilizing second messenger | |
1483 | GR 89696 fumarate |
Subtype-selective κ agonist | |
1484 | Oleylethanolamide |
Lipid mediator, anorexic actions; also GPR55 and PPARα agonist | |
1487 | AY-NH2 |
Selective PAR4 agonist | |
1489 | Mithramycin A |
Inhibitor of DNA and RNA polymerase | |
1490 | MNI-caged-L-glutamate |
Stable photoreleaser of L-glutamate | |
1493 | CGP 78608 hydrochloride |
Potent and selective NMDA antagonist; acts at glycine site | |
1494 | DPN |
Highly potent ERβ agonist | |
1496 | SP 600125 |
Selective JNK inhibitor | |
1497 | Rimcazole dihydrochloride |
σ2 antagonist. Also DAT inhibitor | |
1499 | CL 316243 disodium salt |
Highly selective β3 agonist |